clarus_final_indentity.jpg
Clarus Therapeutics to Present at the Oppenheimer 32nd Annual Healthcare Conference
10 mars 2022 09h05 HE | Clarus Therapeutics Holdings, Inc.
NORTHBROOK, Ill., March 10, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by...